Preparing for PDURS The company is preparing the New Expected Prescription Drug Use-Related Software (PDURS) Model, expected to be finalized later this year
Insurance coverage: Payers are increasingly recognizing obesity as a treatable condition, expanding reimbursement
Benefits of early pharmacologic augmentation Early introduction of anti-obesity medications (AOMs) for GLP-1 agonist non-responders offers several advantages: Enhanced weight reduction : Incorporating phentermine just one month after beginning behavioral therapy more than doubled weight loss compared to placebo (5.9% vs
Frequently Asked Questions Does Medicare ever cover GLP-1s for weight loss in 2026
In recent experiments, Crosbys team tested a vaccine targeting the HER2 protein, a molecule found on the surface of certain aggressive breast cancers
Nausea, vomiting, diarrhea, and constipation are the most frequently reported issues with both peptides